Invention Grant
US08492406B2 Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
有权
使用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮处理滤泡性淋巴瘤的方法
- Patent Title: Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
- Patent Title (中): 使用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮处理滤泡性淋巴瘤的方法
-
Application No.: US12755875Application Date: 2010-04-07
-
Publication No.: US08492406B2Publication Date: 2013-07-23
- Inventor: Jerome B. Zeldis
- Applicant: Jerome B. Zeldis
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: A61K31/445
- IPC: A61K31/445

Abstract:
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Public/Granted literature
Information query
IPC分类: